Replying to @amartinezrubio
@amartinezrubio when to use NT-proBNP in DM?. @ISCPcardio
CKD screening: how, when and to whom @A_Ribasclo @ISCPcardio
Finerenone: a new cardiorenal protector that claims its space @EmiliSanAlv @ISCPcardio
1
2
146
Wine consumption and Mediterranean diet. The key for longevity in Spain? @MAM_UNAV @ISCPcardio
1
1
82
Advances in hypertrophic cardiomyopathy therapy @RebecaLorcaG @ISCPcardio
2
1
90
Clinical implications of albuminuria @DrAmodeo @ISCPcardio
1
58
Non-pharmacological approaches for stroke-risk reduction @Raqueldvfg @ISCPcardio
61
Early rhythm control: dream or reality @DavidCalvo307 @ISCPcardio
59
Are AADs obsolete in the ablation era? @Mallofre_N @ISCPcardio
Challenges in stroke prevention: The role of factor XI inhibitors
MD Víctor García @ISCPcardio
1
64
How to improve drug adherence and treatment persistence
@IvanMaray @ISCPcardio
1
60
Socioeconomic aspects and drug adherence and persistence @amartinezrubio @ISCPcardio
Advances in Fabry-Anderson disease by Ana Fidalgo @ISCPcardio
2
89
Advances in microcirculation therapy. @jckaski @ISCPcardio
50
Is it possible to prevent heart failure due to cancer therapy? @RebecaLorcaG @ISCPcardio





































































